Suchergebnisse - "Ruan, Jia"

PubPharm (209)

51

Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study

enthalten in: Annals of hematology | 2021

von Kim, W. | Oki, Y. | Kim, S. | +26

52

Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study

enthalten in: Annals of hematology | 2021

von Kim, W. | Oki, Y. | Kim, S. | +26

53

Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma

enthalten in: Leukemia & lymphoma | 2021

von Orfali, N. | Jhanwar, Y. | Koo, C. | +23

54

Evaluation of Loading Strategies to Improve Tumor Uptake of Gemcitabine in a Murine Orthotopic Bladder Cancer Model Using Ultrasound and Microbubbles

enthalten in: Ultrasound in medicine & biology | 2021

von Ruan, J. | Browning, R. | Yildiz, Y. | +10

55

Paliurus ramosissimus (Lour.) Poir. extract and preparation methods and uses thereof

enthalten in: Europäisches Patentamt | 2021

von XU CHAOQUN | LI DONGXIAO | SHU GUANGMING | +3

56

Ultrasound-Mediated Gemcitabine Delivery Reduces the Normal-Tissue Toxicity of Chemoradiation Therapy in a Muscle-Invasive Bladder Cancer Model

enthalten in: International journal of radiation oncology, biology, physics | 2021

von Ruan, J. | Browning, R. | Yildiz, Y. | +11

57

Multi-Mode Color-Tunable Long Persistent Luminescence in Single-Component Coordination Polymers

enthalten in: Angewandte Chemie (International ed. in English) | 2021

von Wang, Z. | Zhu, C. | Mo, J. | +4

58

Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients Managed at Chinese Academic Centers in the Rituximab Era : A Real-World Study

enthalten in: Frontiers in oncology | 2021

von Wu, M. | Li, Y. | Huang, H. | +11

59

G Protein-Coupled Estrogen Receptor Agonist G-1 Inhibits Mantle Cell Lymphoma Growth in Preclinical Models

enthalten in: Frontiers in oncology | 2021

von Zhou, L. | Yu, T. | Yang, F. | +10

60

Romidepsin and lenalidomide‐based regimens have efficacy in relapsed/refractory lymphoma : Combined analysis of two phase I studies with expansion cohorts

enthalten in: American Journal of Hematology | 2021

von Mehta‐Shah, N. | Lunning, M. | Moskowitz, A. | +23